[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Microcephaly Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Onset Type Overview

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Congenital

4.2.1    Market Size & Forecast (Value)

4.3       Postnatal

4.3.1    Market Size & Forecast (Value)

5          By Diagnosis Overview

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Magnetic Resonance Imaging (MRI)

5.2.1    Market Size & Forecast (Value)

5.3       Head Computed Tomography (CT) Scan

5.3.1    Market Size & Forecast (Value)

6          Regional Overview

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       America

6.2.1    North America

6.2.1.1 U.S.

6.2.1.1.1          By Onset Type

6.2.1.1.2          By Diagnosis

6.2.1.2 Canada

6.2.1.2.1          By Onset Type

6.2.1.2.2          By Diagnosis

6.2.1.3 Mexico

6.2.1.3.1          By Onset Type

6.2.1.3.2          By Diagnosis

6.2.1.4 Latin America

6.2.1.4.1          By Onset Type

6.2.1.4.2          By Diagnosis

6.3       Europe

6.3.1    Market Size & Forecast (Value)

6.3.2    Germany

6.3.2.1 By Onset Type

6.3.2.2 By Diagnosis

6.3.3    France

6.3.3.1 By Onset Type

6.3.3.2 By Diagnosis

6.3.4    U.K.

6.3.4.1 By Onset Type

6.3.4.2 By Diagnosis

6.3.5    Italy

6.3.5.1 By Onset Type

6.3.5.2 By Diagnosis

6.3.6    Spain

6.3.6.1 By Onset Type

6.3.6.2 By Diagnosis

6.3.7    Rest of Europe

6.3.7.1 By Onset Type

6.3.7.2 By Diagnosis

6.4       Asia Pacific

6.4.1    Market Size & Forecast (Value)

6.4.2    Japan

6.4.2.1 By Onset Type

6.4.2.2 By Diagnosis

6.4.3    China

6.4.3.1 By Onset Type

6.4.3.2 By Diagnosis

6.4.4    Australia

6.4.4.1 By Onset Type

6.4.4.2 By Diagnosis

6.4.5    India

6.4.5.1 By Onset Type

6.4.5.2 By Diagnosis

6.4.6    South Korea

6.4.6.1 By Onset Type

6.4.6.2 By Diagnosis

6.4.7    Rest of Asia-Pacific

6.4.7.1 By Onset Type

6.4.7.2 By Diagnosis

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)

6.5.2    Saudi Arabia

6.5.2.1 By Onset Type

6.5.2.2 By Diagnosis

6.5.3    South Africa

6.5.3.1 By Onset Type

6.5.3.2 By Diagnosis

6.5.4    Kuwait

6.5.4.1 By Onset Type

6.5.4.2 By Diagnosis

6.5.5    Rest of Middle East & Africa

6.5.5.1 By Onset Type

6.5.5.2 By Diagnosis

7          Company Profile

7.1       Abbott Laboratories (Alere Inc.)

7.1.1    Company Overview

7.1.2    Financial Performance

7.1.3    Recent Developments

7.1.4    Product Portfolio

7.2       Beckman Coulter Inc.

7.2.1    Company Overview

7.2.2    Financial Performance

7.2.3    Recent Developments

7.2.4    Product Portfolio

7.3       bioMerieux SA

7.3.1    Company Overview

7.3.2    Financial Performance

7.3.3    Recent Developments

7.3.4    Product Portfolio

7.4       Hologic, Inc.

7.4.1    Company Overview

7.4.2    Financial Performance

7.4.3    Recent Developments

7.4.4    Product Portfolio

7.5       Becton, Dickinson and Company

7.5.1    Company Overview

7.5.2    Financial Performance

7.5.3    Recent Developments

7.5.4    Product Portfolio

7.6       Danaher Corporation

7.6.1    Company Overview

7.6.2    Financial Performance

7.6.3    Recent Developments

7.6.4    Product Portfolio

7.7       Inovio Pharmaceuticals

7.7.1    Company Overview

7.7.2    Financial Performance

7.7.3    Recent Developments

7.7.4    Product Portfolio

7.8       Bio-Rad Laboratories

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio

            7.9       MedMira Inc.

7.9.1    Company Overview

7.9.2    Financial Performance

7.9.3    Recent Developments

7.9.4    Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports